NVJC Ep. 22 Myasthenia Gravis/ALS/Neuromuscular: Morphologic and Molecular Patterns of Polymyositis

NVJC Ep. 59 Myasthenia Gravis/ALS/Neuromuscular: Secondary Generalization in Patients With Ocular MGПодробнее

NVJC Ep. 21 Myasthenia Gravis/ALS/Neuromuscular: SARS-CoV-2 Vaccination Safety in Guillain-BarréПодробнее

NVJC Ep. 20 Myasthenia Gravis / ALS / Neuromuscular: Use of Whole-Genome SequencingПодробнее

NVJC Ep. 18 Myasthenia Gravis/ALS/Neuromuscular: Neuromuscular Features in XL-MTM CarriersПодробнее

NVJC Ep. 52 Myasthenia Gravis/ALS/Neuromuscular: Hastening the Diagnosis of ALSПодробнее

NVJC Ep. 24 Myasthenia Gravis/ALS/Neuromuscular: Randomized Double-Blind Placebo-Controlled TrialПодробнее

NVJC Ep. 25 ALS / MG / Neuromuscular: Involvement of Type I Interferon Signaling in Muscle Stem CellПодробнее

NVJC Ep. 56 Myasthenia Gravis/ALS/Neuromuscular: Exploring Factors That Prolong the Diagnosis of MGПодробнее

NVJC Ep. 57 Myasthenia Gravis/ALS/Neuromuscular: Hospitalizations & Mortality From Myasthenia GravisПодробнее

NVJC Ep. 58 Myasthenia Gravis/ALS/Neuromuscular: Safety & Efficacy of Nipocalimab in Patients w/ MGПодробнее

Novel Therapies in AChR + Myasthenia GravisПодробнее

NVJC Ep. 19 Myasthenia Gravis/ALS/Neuromuscular: Anti-Hu Antibodies in PatientsПодробнее

Genetic mutations and inflammation: understanding the links and improving prognosis in MDSПодробнее